Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Jiangxi Province Ocular Disease Clinical Research Center, Nanchang, 330006 Jiangxi, China.
Departments of Intensive Care, The First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000 Jiangxi, China.
Dis Markers. 2022 Jan 27;2022:1946104. doi: 10.1155/2022/1946104. eCollection 2022.
The purpose of this project is to make sequential and indepth observation of the variations of retinal microvascular, microstructure, and inflammatory mediators at the early stage of diabetic retinopathy (DR) in streptozotocin-induced diabetes mellitus (DM) rats.
DM was induced by a single intraperitoneal injection of 60 mg/kg body weight streptozotocin (STZ). The fluorescein fundus angiography, hematoxylin and eosin staining, periodic acid-Schiff staining, fluorescence imaging techniques, quantitative real-time PCR, and vascular endothelial growth factor- (VEGF-) A ELISA were performed on the 8 day, at the 4 week, 6 week, 8 week, and 10 week after DM induction, respectively.
In this study, we observed not only the decrease of retinal ganglion cells (RGCs) and the increase of endotheliocytes to pericytes (E/P) ratio, acellular capillaries, and type IV collagen-positive strands began to occur on the 8 day after induction but the vascular permeability and new vessel buds began to appear in the diabetes group at the 8 week, while the expression of VEGF-A, VEGF mRNA, IL-6 mRNA, ICAM mRNA, and TNF- mRNA were significantly higher in the diabetes group compared with the normal group( < 0.01) on the 8 day after induction and maintained a high expression level throughout the 10-week observation period. However, the expression of CD18 mRNA began to increase significantly at the 4 week after induction and reached a peak at the 6 week.
Our study indicated the abnormal alterations of microvessels, microstructure, and inflammatory mediators at the early stage of DR, which confirms and supplements the previous research, and also promotes an indepth understanding and exploration of the pathophysiology and underlying pathogenesis of DR.
本项目旨在对链脲佐菌素诱导的糖尿病大鼠糖尿病视网膜病变(DR)早期视网膜微血管、微结构和炎症介质的变化进行连续深入观察。
通过单次腹腔注射 60mg/kg 体重链脲佐菌素(STZ)诱导 DM。在 DM 诱导后第 8 天、第 4 周、第 6 周、第 8 周和第 10 周,分别进行荧光素眼底血管造影、苏木精-伊红染色、过碘酸希夫染色、荧光成像技术、定量实时 PCR 和血管内皮生长因子-(VEGF-)A ELISA。
本研究不仅观察到诱导后第 8 天视网膜神经节细胞(RGC)减少、内皮细胞到周细胞(E/P)比值增加、无细胞毛细血管和 IV 型胶原阳性链开始出现,而且在糖尿病组中,血管通透性和新血管芽开始在第 8 周出现,而 VEGF-A、VEGF mRNA、IL-6 mRNA、ICAM mRNA 和 TNF- mRNA 的表达在诱导后第 8 天明显高于正常组(<0.01),并在 10 周观察期内保持高表达水平。然而,CD18 mRNA 的表达在第 4 周后开始显著增加,并在第 6 周达到峰值。
我们的研究表明,DR 早期微血管、微结构和炎症介质发生异常改变,这既证实和补充了以往的研究,也促进了对 DR 病理生理学和潜在发病机制的深入理解和探索。